focus -WSS

focus

author：leisure time 2025-09-27 23:52:10 - browse：7498

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： How to fix the rural physician shortage in the U.S.

knowledge

hotspot

WSS

Physician groups backed by private equity giant lobby on mergers

New safety details link Apellis eye drug to rare cases of blindness

Novo: Oral version of Ozempic leads to 15% weight loss

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

What the US credit downgrade means for the economy, your finances

Patients, doctors are clashing about side effects of hormonal birth control

leisure time

focus

leisure time

Hollywood unions extend contract negotiations for actors

Amazon expands telehealth clinic nationwide

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Cancer drug shortages should be causing more outrage

No plane should take off without an EpiPen onboard

How one medical school became remarkably diverse

Millions may soon lose Medicaid when they don't have to

The cancer drug shortage isn’t new — and neither are the solutions

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

entertainment

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

FDA approves first new drug developed for postpartum depression

New safety details link Apellis eye drug to rare cases of blindness

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

No plane should take off without an EpiPen onboard

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

knowledge

hotspot

Wikipedia

focus